Biotechnology

Amarin (NASDAQ: AMRN) reported second quarter 2020 results yesterday. During the earnings conference call, the management and the analysts discussed…

Immunogen Inc  (NASDAQ: IMGN) Q2 2020 earnings call dated July 31, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications…

ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period.…

Vertex Pharmaceuticals Inc  (NASDAQ: VRTX) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Michael Partridge -- Senior Vice President, Investor…

Gilead Sciences Inc  (NASDAQ: GILD) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Douglas Maffei -- Senior Director, Investor Relations…

Gilead Sciences (NASDAQ: GILD) reported second-quarter financial results after the closing bell on Thursday. The biotechnology firm missed both the…

Amgen Inc  (NASDAQ: AMGN) Q2 2020 earnings call dated July 28, 2020 Corporate Participants: Arvind Sood -- Vice President of Investor Relations…

Biogen Inc. (NASDAQ: BIIB) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Joe Mara -- Vice President of Finance and…

Novartis International AG (NYSE: NVS) Q2 2020 earnings call dated Jul. 21, 2020 Corporate Participants: Samir Shah -- Global Head of Investor…

Biogen (NASDAQ: BIIB) reported a 12% increase in adjusted EPS and 2% growth in revenue for the second quarter of…

Moderna Inc  (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call dated July 15, 2020 Corporate Participants:…

A diverse population with varying infection rates will be among the biggest challenges during the phase 3 trials of its…

Avid Bioservices, Inc.  (CDMO) Q4 2020 earnings call dated June 30, 2020 Corporate Participants: Tim Brons -- Executive Vice President Rick Hancock -- Interim…

Nektar Therapeutics (NKTR) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Jennifer Ruddock -- Senior Vice President, Strategy and Corporate…

The patent war between Amarin (NASDAQ: AMRN) and the generic companies for cardiovascular drug Vascepa continues to be a headwind…

Affimed N.V. (AFMD) Q1 2020 earnings call dated Jun. 23, 2020 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi Hoess -- Chief…

Eli Lilly & Co.’s (NYSE: LLY) shares have gained 29% since the beginning of the year and 16% over the…

FibroGen Inc (FGEN) Q1 2020 earnings call dated May 08, 2020 Corporate Participants: Michael Tung -- Corporate Strategy Investor Relations Enrique Conterno -- Chief…

Ionis Pharmaceuticals Inc. (IONS) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Wade Walke, Ph.D. -- Vice President, Investor Relations…

Xenon Pharmaceuticals Inc (XENE) Q1 2020 earnings call dated May 21, 2020 Corporate Participants: Jodi Regts -- Vice President, Corporate Affairs and…

Karyopharm Therapeutics Inc (KPTI) Q1 2020 earnings call dated May 05, 2020 Corporate Participants: Ian Karp -- Vice President, Investor and Public…